Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00487279 · ClinicalTrials.gov registry record · NA

DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation

A NA study, sponsored by Abbott Medical Devices.

Terminated
Registry status
NA
Development phase
81
Enrollment target

NCT00487279 is a NA study that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 81 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00487279, a NA study, was terminated before completion, sponsored by Abbott Medical Devices.

TERMINATED
Registry status
NA
Development phase
81 participants
Enrollment target

Study Summary

This trial is a prospective, multi-center, randomized study of patients with coronary artery disease (CAD) and mild to moderate left ventricular (LV) dysfunction. The primary objective of this study is to test the hypothesis that Implantable Cardioverter Defibrillator (ICD) therapy in combination with medical therapy in patients with an infarct size greater than or equal to 10% of the left ventricular mass improves long term survival compared to medical therapy alone. In addition to the 2-arm randomized trial, the study will also include a non-investigational registry of non-randomized patients.

Interventions

  • OTHER Control
  • DEVICE Defibrillator

Trial Details

FieldValue
Enrollment Target 81 participants
Start Date 2007-06
Est. Completion 2011-04
Phase NA

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT00487279

The ClinicalTrials.gov registry entry for NCT00487279 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.

NCT00487279 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00487279 about?

NCT00487279 is a clinical study titled "DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation". This trial is a prospective, multi-center, randomized study of patients with coronary artery disease (CAD) and mild to moderate left ventricular (LV) dysfunction. The primary objective of this study is to test the hypothesis that Implantable Cardioverter Defibrillator (ICD) therapy in combination wi...

What is the current status of trial NCT00487279?

This trial is currently terminated. It is a NA study. The enrollment target is 81 participants. The study started on 2007-06. Estimated completion is 2011-04.

What interventions are being tested in trial NCT00487279?

The interventions under investigation include: Control (OTHER), Defibrillator (DEVICE).

Who is sponsoring clinical trial NCT00487279?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.